In rapid diagnostic identification, what is the correct sequence after a positive blood culture?

In rapid diagnostic identification, what is the correct sequence after a positive blood culture?

• A. Gram stain followed by biochemical tests
• B. Gram stain followed by a rapid diagnostic test
• C. Rapid diagnostic test followed by Gram stain
• D. Biochemical tests after Gram stain

Answer: (B)

After a blood culture turns positive, speed in identifying the pathogen matters for guiding treatment. Start with a Gram stain of the culture broth to quickly categorize the organism as Gram-positive or Gram-negative and to get a sense of its morphology (cocci vs. rods). This rapid, broad classification provides immediate, actionable information and sets the stage for a targeted, rapid identification step. Following the Gram stain, apply a rapid diagnostic test. These tests are designed to quickly pinpoint the organism once a positive culture is available, and performing them after the Gram result helps ensure the right test is used and the results are interpreted in the correct context. Rapid tests (such as MALDI-TOF or molecular panels) can provide species-level identification much faster than traditional biochemical panels, enabling earlier targeted therapy. Doing rapid testing before Gram staining would miss the immediate morphological context and isn’t the standard workflow, and relying solely on biochemical tests after Gram staining would delay results because biochemical panels take longer to complete.

After a blood culture turns positive, speed in identifying the pathogen matters for guiding treatment. Start with a Gram stain of the culture broth to quickly categorize the organism as Gram-positive or Gram-negative and to get a sense of its morphology (cocci vs. rods). This rapid, broad classification provides immediate, actionable information and sets the stage for a targeted, rapid identification step.

Following the Gram stain, apply a rapid diagnostic test. These tests are designed to quickly pinpoint the organism once a positive culture is available, and performing them after the Gram result helps ensure the right test is used and the results are interpreted in the correct context. Rapid tests (such as MALDI-TOF or molecular panels) can provide species-level identification much faster than traditional biochemical panels, enabling earlier targeted therapy.

Doing rapid testing before Gram staining would miss the immediate morphological context and isn’t the standard workflow, and relying solely on biochemical tests after Gram staining would delay results because biochemical panels take longer to complete.